Fortunately, some neutralizing antibodies against IL-1α and TNF-α are already in practical use for treating cancers, rheumatoid arthritis, and other chronic local inflammatory diseases [70, 71]. The gene discussed is TNF; the disease is rheumatoid arthritis.